Multiple Sclerosis

The NeurologyLive® MS Disease Spotlight page offers specific updates and coverage on the latest expert conversations and data readouts related to the treatment and management of patients with multiple sclerosis and demyelinating disorders.

Latest News

Published Phase 2 Findings Highlight CD40L Inhibitor Frexalimab as Potential Treatment for Multiple Sclerosis
Published Phase 2 Findings Highlight CD40L Inhibitor Frexalimab as Potential Treatment for Multiple Sclerosis

February 18th 2024

In addition the reductions in the number of new gadolinium-enhancing lesions, frexalimab lowered plasma levels of neurofilament light and CXCL13, a biomarker of inflammatory activity.

 Kelly Papesh, DNP, APRN, FNP-BC, the clinical director of the Parkinson & Movement Disorder Alliance (PMD Alliance)
A 2024 Clinical Preview: What Are Neurologists Excited About?

February 16th 2024

Nananda Col, MD, MPH, MPP, FACP
Multiple Sclerosis Treatment Decision-Making With MS-SUPPORT Tool

February 8th 2024

Longitudinal EVOLVE-MS-1 Study Demonstrates Diroximel Fumarate's Effective Profile in Relapsing MS
Longitudinal EVOLVE-MS-1 Study Demonstrates Diroximel Fumarate's Effective Profile in Relapsing MS

February 5th 2024

Case Study Reports Positive Impact of Antiviral Therapy Tenofovir in MS, Warranting Further Research
Case Study Reports Positive Impact of Antiviral Therapy Tenofovir in MS, Warranting Further Research

February 3rd 2024

© 2024 MJH Life Sciences

All rights reserved.